Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2092]

AACR 2021: Researchers identify surface protein as a new osteosarcoma therapeutic target for antibody-drug conjugates

AACR 2021: Researchers identify surface protein as a new osteosarcoma therapeutic target for antibody-drug...

Drug testing approach uncovers effective combination for treating small cell lung cancer

Drug testing approach uncovers effective combination for treating small cell lung cancer

Cancer DNA blood tests validated by international research team

Cancer DNA blood tests validated by international research team

AACR 2021: Immunotherapy response prediction using tumour mutational burden may differ between men and women with melanoma

AACR 2021: Immunotherapy response prediction using tumour mutational burden may differ between men and women with...

AACR 2021: CREB1 identified as potential therapeutic target for the treatment of pancreatic cancer

AACR 2021: CREB1 identified as potential therapeutic target for the treatment of pancreatic cancer

AACR 2021: Personalised cancer vaccine given after adjuvant therapy safe, shows early efficacy in multiple tumour types

AACR 2021: Personalised cancer vaccine given after adjuvant therapy safe, shows early efficacy in multiple tumour...

AACR2021: Early-onset colorectal cancers from patients of different races may exhibit distinct genetic features

AACR2021: Early-onset colorectal cancers from patients of different races may exhibit distinct genetic features

$AACR 2021: Bispecific CAR T-cell therapy shows early promise for relapsed or refractory B-cell lymphoma$

AACR 2021: Bispecific CAR T-cell therapy shows early promise for relapsed or refractory B-cell lymphoma

AACR 2021: Cancer aneuploidy may predict responses to immunotherapy in patients with non-small cell lung cancer

AACR 2021: Cancer aneuploidy may predict responses to immunotherapy in patients with non-small cell lung cancer

Artificial Intelligence could 'crack the language of cancer and Alzheimer's'

Artificial Intelligence could 'crack the language of cancer and Alzheimer's'

More from ecancer